In brief

Key points

  • Trulicity contains dulaglutide, a GLP-1 receptor agonist, and is injected once weekly.
  • Its Canadian indication is for adults with type 2 diabetes under its monograph.
  • The DPD records each strength and presentation separately; one record does not establish every presentation’s market status.

Trulicity at a glance

A prescription dulaglutide product authorized for adults with type 2 diabetes. Drug Product Database status is recorded separately for each DIN and presentation.[1]

Trulicity product overview, checked August 14, 2026
IngredientClassRouteFrequencyAuthorized-use focus
dulaglutideGLP-1 receptor agonistSubcutaneous injectionOnce weeklyType 2 diabetes

Trulicity is dulaglutide, with presentation-level records

Trulicity is not semaglutide or tirzepatide. Compare exact products in the Canadian medication overview and keep ingredient-level claims attached to the right medicine.

When checking availability or coverage, use the exact DIN on the prescription or package. A general brand search may combine approved, marketed and other presentation-level records.[1][2]

Weekly frequency is only one part of assessment

A diabetes assessment covers the current regimen, treatment goals, other medicines, medical history, contraindications, monitoring and whether a weekly injection is practical. It does not begin with a universal brand ranking.

A single Trulicity record cannot represent every strength

The cited DPD record is DIN 02448602. Health Canada records strengths and presentations separately, so verify the DIN on the prescription or package before describing its lifecycle, availability or coverage.

An Approved or Marketed status has a defined regulatory meaning; neither is a promise of nearby stock. Use the exact presentation for the plan inquiry and the same-prescription pharmacy quote.[2][3][4]

Evidence

Sources

  1. Trulicity (dulaglutide injection) Product MonographHealth Canada / Eli Lilly Canada · Checked August 14, 2026
  2. Trulicity product record (DIN 02448602)Health Canada Drug Product Database · Checked August 14, 2026
  3. Drug Product Database terminologyHealth Canada · Checked August 14, 2026
  4. Understanding health insuranceFinancial Consumer Agency of Canada · Checked August 14, 2026